Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis
- PMID: 35157250
- DOI: 10.1007/s40261-022-01126-w
Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis
Erratum for
-
Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.Clin Drug Investig. 2021 Nov;41(11):941-953. doi: 10.1007/s40261-021-01091-w. Epub 2021 Oct 13. Clin Drug Investig. 2021. PMID: 34643934
Publication types
LinkOut - more resources
Full Text Sources
